The LARK/RBM4a protein is highly expressed in cerebellum as compared to cerebrum

Neuroscience Letters

Volumn 444, Issue 1, 2008, Pages 11-15

  Pfuhl, Thorsten ^a   Mamiani, Alfredo ^a   Dürr, Matthias ^a   Welter, Susanne ^a   Stieber, Johanna ^a   Ankara, Jasmin ^a   Liss, Michael ^b   Dobner, Thomas ^c   Schmitt, Andrea ^d   Falkai, Peter ^d   Kremmer, Elisabeth ^e   Jung, Volker ^a   Barth, Stephanie ^a   Grässer, Friedrich A ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Geneart AG   (Germany)

^c LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Alternative spilcing; Brain; Cerebellum; Cerebrum; Hlark; Kidney; Lark; Liver; mAb; Monoclonal antibodies; Protein expression; RBM4; RBM4a; RBM4b; RISC; RNA binding motif 4 protein; Splicing; Tau; Tauopathy; Tumour

Indexed keywords

LARK PROTEIN; MONOCLONAL ANTIBODY; RBM4A PROTEIN; RBM4B PROTEIN; RNA BINDING PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BRAIN; CEREBELLUM; CONTROLLED STUDY; FEMALE; FOREBRAIN; HALF LIFE TIME; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY; LIVER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION;

ANIMALS; CEREBELLUM; CEREBRUM; EPITOPE MAPPING; HALF-LIFE; HELA CELLS; HUMANS; RABBITS; RATS; RNA-BINDING PROTEINS; TIME FACTORS; UP-REGULATION;

EID: 51049104826     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.08.017     Document Type: Article

References (20)

1. Bernert G., Fountoulakis M., and Lubec G. Manifold decreased protein levels of matrin 3, reduced motor protein HMP and hlark in fetal Down's syndrome brain. Proteomics 2 (2002) 1752-1757
2. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., and Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. (Berl.) 112 (2006) 389-404 (Epub 2006 August 2012)
3. Braak H., and Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82 (1991) 239-259
4. D'Souza I., and Schellenberg G.D. Regulation of tau isoform expression and dementia. Biochim. Biophys. Acta 1739 (2005) 104-115
5. Dennis S.L., Manji S.S., Carrington D.P., Scarcella D.L., Ashley D.M., Smith P.J., and Algar E.M. Expression and mutation analysis of the Wilms' tumor 1 gene in human neural tumors. Int. J. Cancer 97 (2002) 713-715
6. Gulesserian T., Engidawork E., Fountoulakis M., and Lubec G. Decreased brain levels of Lupus La protein and increased U5 small ribonucleoprotein-specific 40 kDa protein in fetal Down syndrome. Cell Mol. Biol. (Noisy-le-grand) 49 (2003) 733-738
7. Hock J., Weinmann L., Ender C., Rudel S., Kremmer E., Raabe M., Urlaub H., and Meister G. Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. EMBO Rep. 12 (2007) 12
8. Jackson F.R., Banfi S., Guffanti A., and Rossi E. A novel zinc finger-containing RNA-binding protein conserved from fruitflies to humans. Genomics 41 (1997) 444-452
9. Kar A., Havlioglu N., Tarn W.Y., and Wu J.Y. RBM4 interacts with an intronic element and stimulates tau exon 10 inclusion. J. Biol. Chem. 15 (2006) 15
10. Kremmer E., Kranz B., Hille A., Klein K., Eulitz M., Hoffmann-Fezer G., Feiden W., Herrmann K., Delecluse H.-J., Delsol G., Bornkamm G.W., Mueller-Lantzsch N., and Grässer F.A. Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B). Virology 208 (1995) 336-342
11. Lai M.C., Kuo H.W., Chang W.C., and Tarn W.Y. A novel splicing regulator shares a nuclear import pathway with SR proteins. EMBO J. 22 (2003) 1359-1369
12. Lin J.C., Hsu M., and Tarn W.Y. Cell stress modulates the function of splicing regulatory protein RBM4 in translation control. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 2235-2240 (Epub 2007 February 2236)
13. Lin J.C., and Tarn W.Y. Exon selection in alpha-tropomyosin mRNA is regulated by the antagonistic action of RBM4 and PTB. Mol. Cell. Biol. 25 (2005) 10111-10121
14. Markus M.A., Heinrich B., Raitskin O., Adams D.J., Mangs H., Goy C., Ladomery M., Sperling R., Stamm S., and Morris B.J. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo. Exp. Cell. Res. 25 (2006) 25
15. Markus M.A., and Morris B.J. Lark is the splicing factor RBM4 and exhibits unique subnuclear localization properties. DNA Cell. Biol. 25 (2006) 457-464
16. McNeil G.P., Smith F., and Galioto R. The Drosophila RNA-binding protein Lark is required for the organization of the actin cytoskeleton and Hu-li tai shao localization during oogenesis. Genesis 40 (2004) 90
17. Newby L.M., and Jackson F.R. Regulation of a specific circadian clock output pathway by lark, a putative RNA-binding protein with repressor activity. J. Neurobiol. 31 (1996) 117-128
18. Romeike B.F., Jung V., Feiden W., Moringlane J.R., Zang K.D., and Urbschat S.M. Distribution of epidermal growth factor receptor protein correlates with gain in chromosome 7 revealed by comparative genomic hybridization after microdissection in glioblastoma multiforme. Pathol., Res. Pract. 197 (2001) 427-431
19. Williams D.R., Holton J.L., Strand C., Pittman A., de Silva R., Lees A.J., and Revesz T. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain 130 (2007) 1566-1576
20. Zhang X., McNeil G.P., Hilderbrand-Chae M.J., Franklin T.M., Schroeder A.J., and Jackson F.R. Circadian regulation of the lark RNA-binding protein within identifiable neurosecretory cells. J. Neurobiol. 45 (2000) 14-29